Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

49.90
-0.0900-0.18%
Post-market: 49.50-0.4000-0.80%19:58 EDT
Volume:1.67M
Turnover:82.80M
Market Cap:6.18B
PE:-14.77
High:50.55
Open:50.20
Low:48.70
Close:49.99
Loading ...

BRIEF-Guardant Health Announced the results of the Serena-6 Phase III Trial

Reuters
·
02 Jun

Guardant Health's Phase III Trial Highlights Guardant360 CDx Test's Role in Early Detection of Therapy Resistance in Breast Cancer

Reuters
·
02 Jun

Serena-6 Phase Iii Trial Demonstrates Clinical Value of Guardant360 Cdx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer

THOMSON REUTERS
·
02 Jun

Guardant Health presented results of largest study on ctDNA in colon cancer

TIPRANKS
·
02 Jun

New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report

Dow Jones
·
23 May

Guardant Health Launches Immunohistochemistry Testing for Solid Tumors

MT Newswires Live
·
22 May

Guardant Health Unveils Comprehensive IHC Testing for Enhanced Cancer Therapy Selection

Reuters
·
21 May

Director Tariq Musa Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
21 May

BRIEF-Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer

Reuters
·
20 May

Guardant Health - Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer

THOMSON REUTERS
·
20 May

Guardant Health Inc. Launches Hereditary Cancer Test to Improve Personalized Cancer Care and Risk Assessment

Reuters
·
20 May

GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating

TIPRANKS
·
10 May

GH Research Is Maintained at Buy by Guggenheim

Dow Jones
·
10 May

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
09 May

Psychedelic: Compass, GH Research, MindMed report quarterly earnings

TIPRANKS
·
08 May

GH Research Q1 EPS $(0.19) Beats $(0.39) Estimate

Benzinga
·
08 May

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 May

Cathie Wood’s ARK Investment buys 237.4K shares of Guardant Health today

TIPRANKS
·
07 May

Guardant Health Is Maintained at Overweight by Piper Sandler

Dow Jones
·
07 May

AmirAli Talasaz, Co-CEO of Guardant Health Inc., Reports Disposal of Common Shares

Reuters
·
06 May